NERI, Sergio
 Distribuzione geografica
Continente #
NA - Nord America 8.651
EU - Europa 4.248
AS - Asia 4.099
SA - Sud America 780
AF - Africa 500
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 9
Totale 18.296
Nazione #
US - Stati Uniti d'America 8.284
SG - Singapore 2.186
RU - Federazione Russa 1.249
CN - Cina 1.132
UA - Ucraina 828
IE - Irlanda 758
IT - Italia 663
BR - Brasile 646
CA - Canada 315
VN - Vietnam 304
CI - Costa d'Avorio 245
FR - Francia 237
NG - Nigeria 135
GB - Regno Unito 121
SE - Svezia 119
KR - Corea 96
IN - India 90
DE - Germania 72
BD - Bangladesh 59
AR - Argentina 49
SN - Senegal 40
TR - Turchia 32
MX - Messico 30
HK - Hong Kong 29
IQ - Iraq 29
NL - Olanda 28
PL - Polonia 28
ZA - Sudafrica 25
AT - Austria 23
CH - Svizzera 21
BE - Belgio 18
CO - Colombia 18
JP - Giappone 17
MA - Marocco 17
FI - Finlandia 16
UZ - Uzbekistan 16
EC - Ecuador 15
VE - Venezuela 15
ES - Italia 13
PK - Pakistan 13
PY - Paraguay 13
BG - Bulgaria 11
CZ - Repubblica Ceca 10
CL - Cile 9
EU - Europa 9
GR - Grecia 9
IR - Iran 9
KE - Kenya 9
MY - Malesia 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
ID - Indonesia 7
NP - Nepal 7
PH - Filippine 7
HN - Honduras 6
JO - Giordania 6
SA - Arabia Saudita 6
UY - Uruguay 6
DZ - Algeria 5
EG - Egitto 5
KZ - Kazakistan 5
TN - Tunisia 5
GH - Ghana 4
IL - Israele 4
LB - Libano 4
LT - Lituania 4
OM - Oman 4
BH - Bahrain 3
BO - Bolivia 3
ET - Etiopia 3
GE - Georgia 3
KG - Kirghizistan 3
PA - Panama 3
PE - Perù 3
PR - Porto Rico 3
RO - Romania 3
SR - Suriname 3
SY - Repubblica araba siriana 3
AO - Angola 2
AZ - Azerbaigian 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HR - Croazia 2
LV - Lettonia 2
PS - Palestinian Territory 2
RS - Serbia 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CY - Cipro 1
HU - Ungheria 1
JM - Giamaica 1
KW - Kuwait 1
LU - Lussemburgo 1
Totale 18.286
Città #
Dallas 1.378
Singapore 1.234
Santa Clara 1.002
Jacksonville 823
Dublin 752
Chandler 689
San Jose 525
Moscow 456
Chicago 352
Ashburn 332
Boardman 322
Nanjing 251
Abidjan 245
Toronto 225
Lawrence 211
Cambridge 208
Andover 206
Lauterbourg 186
Houston 176
Los Angeles 164
Beijing 162
Civitanova Marche 124
Ho Chi Minh City 108
San Mateo 107
Catania 105
Des Moines 104
Seoul 94
Abuja 86
Hefei 85
Wilmington 85
Nanchang 75
Hanoi 70
São Paulo 63
Shenyang 61
New York 60
Hebei 57
Saint Petersburg 55
Jiaxing 49
Ottawa 47
Changsha 46
Buffalo 45
Milan 43
Dakar 40
Council Bluffs 39
Tianjin 38
Lagos 36
Civitavecchia 29
Brooklyn 23
Montreal 23
The Dalles 23
Orem 22
Hong Kong 20
Seattle 20
Columbus 19
Warsaw 19
Brussels 18
Johannesburg 18
Belo Horizonte 17
Bremen 17
Da Nang 17
Tokyo 16
Baghdad 15
Chennai 15
Jinan 15
Kunming 15
Poplar 15
Rio de Janeiro 15
Rome 15
Boston 14
Haiphong 14
London 14
Pune 14
Ann Arbor 13
Denver 13
Leawood 13
Port Harcourt 13
San Francisco 13
Hyderabad 12
Ankara 11
Buenos Aires 11
Hangzhou 11
Redondo Beach 11
Atlanta 10
Brasília 10
Curitiba 10
Mexico City 10
Mumbai 10
Ribeirão Preto 10
Amsterdam 9
Augusta 9
Dhaka 9
Munich 9
Phoenix 9
Porto Alegre 9
Secaucus 9
Shanghai 9
Stockholm 9
Elk Grove Village 8
Fortaleza 8
Liberty Lake 8
Totale 12.369
Nome #
A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis 334
Assessing degree of hepatic fibrosis in patients with chronic liver disease using gadoxetic acid-enhanced liver MRI: Preliminary results 181
LA DIAGNOSI DELLA SINDROME DELL'ARTERIA MESENTERICA SUPERIORE 177
A randomized, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment of patients with peripheral arterial disease and haemodialysis with propyonil L-carnitine 175
Acquired angioedema of the glottis, larynx and neck in a patient affected by SLE: case report 167
Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase -2 in patients with HCV-related chronic hepatitis. Relationship to histological features 167
Carotid Intima-Media Thickness and Liver Histology in Hemodialysis Patients with Non-Alcoholic Fatty Liver Disease 165
Acute renal failure in Plasmodium malariae infection 158
An unusual case of post-trasfusion malaria 157
Immune response in addicts with chronic hepatitis C treated with interferon and ribavirine 154
Plasma Levels of Inflammatory Biomarkers in Peripheral Arterial Disease: Results of a Cohort Study 150
Obesity and related diseases: an epidemiologic study in Eastern Sicily 145
Meaning of elevated CA 19-9 serum levels in chronic hepatitis and HCV-related cirrhosis 141
Association Between Diabetes Mellitus, Hepatic Steatosis And Fibrosis In Chronic Hepatitis C Patients 141
Eterozigosi H36D per Emocromatosi in pazienti affetti da Steatoepatite e Epatite cronica da virus C 141
A therapeutic education and medical support program improves adherence to therapy with peg-interferon plus ribavirin therapy and increases sustained virological response in patients with chronic hepatitis C 141
A Multidisciplinary Therapeutic Approach for Reducing the Risk of Psychiatric Side Effects in Patients With Chronic Hepatitis C Treated With Pegylated Interferon α and Ribavirin 141
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 140
An unusual case of genodermatosis with familial gastrointestinal polyposis, angiomatous malformation and ascites 137
Addome 136
A case of Overlap Syndrome:Autoimmune idiopatic hepatitis/pulmonary idiopatic hypertension 134
AN UNUSUAL CASE OF GENODERMATOSE WITH FAMILIAL GASTROINTESTINAL POLYPOSIS, ANGIOMATOUS MALFORMATION AND ASCITES 133
Organic or psychiatric disease? A misdiagnosed superior mesenteric artery syndrome 133
Carbohydrate 19-9 antigen in chronic viral hepatitis without neoplasia is associated with the severity of liver disease 131
A hyperdynamic portal syndrome with ascites after endoscopic laser treatment 131
Behaviour of some indicators of oxidative stress in postmenopausal and fertile women 131
A case of acute abdomen for the internist 130
Alteration of oxide-reductive and haemostatic factors in type 2 diabetics 130
Fibrosi polmonare idiopatica: caso clinico [Idiopathic pulmonary fibrosis. A case report] 129
Acetyl L-carnitine (ACL) treatment in elderly patients with fatigue 129
Effect of LPC on functional parameters and oxidative profile in type 2 diabetes-associated PAD 127
A STUDY OF CUPREMIA IN A GROUP OF ELDERLY DIABETICS 126
A case of progression from type II cryoglobulinaemia to Waldenstrom's macroglobulinaemia in a patient with chronic hepatitis C 125
PATOLOGIA JATROGENA ACUTA IN CORSO DI IPERTENSIONE POLMONARE CRONICA(CUORE POLMONARE CRONICO. CONSIDERAZIONI A PROPOSITO DI UNA OSSERVAZIONE PERSONALE 124
A nationawide survey of hereditary angioedema due to C1 inhibitor defciency in Italy 122
ON-TREATMENT SERUM HBsAG DECLINE DURING TELBIVUDINE THERAPY IN NAÏVE CHRONIC HEPATITIS B: CASE REPORT 122
Eritropoietina nel trattamento dell'anemia secondaria a terapia con interferone peghilato e ribavirina 121
Verrucous Psoriasis in a Patient with Chronic C Hepatitis Treated with Interferon 120
Patients with unrecognized peripheral arterial disease (PAD) assessed by ankle-brachial index (ABI) present a defined profile of proinflammatory markers compared to healthy subjects 120
An Unusual Case of Cerebral Oedema 116
Vision loss due to atypical bilateral edema of the optic nerve in a patient with hereditary angioedema: A case report 114
Liver immunolocalization and plasma levels of MMP-9 in non-alcoholic steatohepatitis (NASH) and hepatitis C infection 114
Duration of menopause and behaviour of malondialdehyde, lipids, lipoproteins and carotid wall artery intima – media thickness 113
Changes in splenoportal axis calibre and flow in a patient affected by hereditary angioedema 112
Rosuvastatin reduces non alcoholic fatty liver diseasa in patients with chronic hepatitis C treated with alpha-interferon and ribavirin 112
The HFE gene heterozygosis H63D: a cofactor for liver damage in patients with steatohepatitis? Epidemiological and clinical considerations 112
Duration of menopause and behaviour of malondialdehyde, lipids, lipoproteins and carotid wall intima-media thickenss 109
Trattamento con peg-interferone e ribavirina nell’epatite cronica attiva C ed insorgenza di malattia celiaca: esiste una relazione ? 109
Eritropoietina nel trattamento dell’anemia secondaria a terapia con interferone peghilato e ribavirina 107
The Relationship between Body Dissatisfaction and Eating Disorder Symptoms in Young Women Aspiring Fashion Models: The Mediating Role of Stress 105
Endothelin-1 and endothelial damage in elderly patients 104
Diagnostic abd therapeutic management of hereditary angioedema due to C1-inhibitor deficiency: the italian experience 102
Co-administration ezetimibe/simvastatin teraphy decrease the supersaturation in gallbladder bile and prevent cholesterol gallstones formation 100
ON-TREATMENT HBsAg DECLINE IS ASSOCIATED WITH SUBSEQUENT HBsAg REDUCTION IN HBeAg NEGATIVE CHRONIC HEPATITIS B 100
Ferro e ferrodeplezione nell'epatite cronica HCV-correlata 99
Oxidative stress, nitric oxide, endothelial dysfunction and tinnitus 97
Angioedema ereditario da carenza di C1 inibitore. Consensus italiano per la diagnosi e la terapia 97
Endothelin-1 in arterial hypertension after cold pressor test 95
POST-LOAD INSULIN RESISTANCE IS AN INDEPENDENT PREDICTOR OF HEPATIC FIBROSIS IN DIABETIC PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 95
Ferro e ferrodeplezione nell'epatite cronica HCV-correlata.Studio pilota 94
Un raro caso di epatite acuta da farmaci 93
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor. 93
CO-ADMINISTRATION EZETIMIBE/SIMVASTATIN TERAPHY DECREASES THE SUPER-SATURATION IN GALLBLADDER BILE AND PREVENT CHOLESTEROL GALLSTONES FORMATION 93
Does endothelin-1 play a role in the renal function of cirrhotic patients? 92
Ultrasonography in diagnosis and evaluation of fibrocystic liver disease: two case reports 92
Role of Ademetionine (S-Adenosylmethionine) in cyclosporin-induced cholestasis 92
Isomorphic response in eruptive xanthomas 92
La metalloproteinasi-2 è un marker indiretto di citonecrosi e fibrosi epatica nell’epatite cronica HCV-correlata 92
INFEZIONE DA HAV IN PAZIENTI CON EPATITE CRONICA HCV-CORRELATA 92
Visceral adipose tissue area as independent risk factor of elevated alanine aminotransferase 91
COMPLICATION AND HOSPITALISATION AFTER PERCUTANEOUS LIVER BIOPSY: A COHORT STUDY OF 12 YARS 91
Pegylated-interferon and ribavirin therapy of HCV-related type II mixed cryoglobulinemia 91
PRELIEVO VENOSO RENALE PER IL DOSAGGIO DELLA PRA IN SOGGETTI CON IPERTENSIONE SISTO-DIASTOLICA E QUADRI ARTERIOGRAFICI SUGGESTIVI PER LESIONI VASCULO-PARENCHIMALI RENALI 90
Plasma ICAM-1 and VCAM-1 levels in type 2 diabetic patients with and without microalbuminuria 90
Evaluation of circulating CD4⁺CD25⁺ and liver-infiltrating Foxp3⁺ cells in HCV-associated liver disease 89
CONTRIBUTO SUL COMPORTAMENTO DELLA MIOGLOBINEMIA NELL'IMA: CORRELAZIONI SIERO-ENZIMATICHE, SIGNIFICATO CLINICO. PARTE I. STUDIO IN UNA CASISTICA SELEZIONATA DI SOGGETTI CON IMA IN FASE PRECOCE 88
Combination therapy with pegylated-Interferon and Ribavirin determines a decrease in Squamous Cell Carcinoma Antigen (SCCA)-Immunoglobulin M (IgM) complex (SCCA-IgM IC) serum levels in patients with HCV-related liver cirrhosis 88
Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group 87
Iron depletion and lifestyle modifications improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia 87
Relation of non-alcoholic hepatic steatosis to early carotid atherosclerosis in diet-controlled impaired glucose tolerance subjects 86
URSODEOXYCHOLIC ACID AND SIMVASTATIN IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE AND METABOLIC SYNDROME 86
Diagnosis of renovascular disease by extra-end intrarenal doppler parameters 85
Steatohepatites Influence The Cardiovascular And Diabetus Mellitul Risk Profile 85
Epoetin alpha improves the response to antiviral treatment in HCV-related chronic hepatitis 85
Un caso di acidosi tubulare da causa jatrogena 85
PERIHEPATIC LYMPHADENOPATHY IN CHRONIC C HAPATITIS; A COMPLEMENTARY DIAGNOSTIC ELEMENT? 84
Oxidative stress and white blood cell activation in chronic and severe ischemia of peripheral vascular disease 84
Drug Rash With Eosinophilia and Systemic Signs Syndrome in a Patient With Multiple Sclerosis 84
Infections: Patients with Peripheral Arterial Disease and Those with Risk Factors for Cardiovascular Diseases Compared to Normal Subjects 84
Biliary hamartomas (von Mayenburg complex): magnetic resonance imaging in a case report 83
Gordon’s Sindrome: A Case Report 83
Randomized clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusers 83
Propyonil-L-carnitine therapy: effects on endothelin-1 and homocysteine levels in patients with peripheral arterial disease (PAD) and end stage renal disease (ESRD) 83
Infezione da HAV in pazienti con epatite cronica HCV correlata 82
Isotretinoin in Perifolliculitis capitis abscedens et suffodiens: A case report and review of the literature 81
URSODEOXYCHOLIC ACID AND SIMVASTATIN IN PATIENTS WITHNONALCOHOLIC FATTY LIVER DISEASE AND METABOLIC SYNDROME 81
PEG-Interferone alfa 2a versus Lamivudina nel trattamento dell’epatite cronica HbeAg negativa/HbeAb positiva. Studio pilota 81
La Sindrome Epatorenale 81
Oxidative stress, glutathione status, sirtuin and cellular stress response in type 2 diabetes 81
Effect of long-term hormon replacement therapy: results from a cohort study 80
Totale 11.342
Categoria #
all - tutte 62.005
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.005


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202144 0 0 0 0 0 0 0 0 0 0 0 44
2021/20221.504 212 219 11 31 229 6 219 53 137 1 58 328
2022/20232.211 227 86 28 166 234 393 7 376 557 27 74 36
2023/2024846 57 135 40 52 51 124 26 39 4 20 215 83
2024/20253.694 54 650 223 190 768 472 84 151 267 368 189 278
2025/20267.084 452 271 1.518 399 1.139 1.364 948 130 352 269 168 74
Totale 18.581